The article discusses the impact of proton-pump inhibitor acid blocking prescription drugs on the bacteriology and microbiome of the human digestive system and risk for intestinal infections. Other topics include bacterial diversity, absorption of calcium, and management by physicians and patients of prescription medication.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados